Evidence map›Paper›PMID 34833838›Full record

ArticleSensors (Basel, Switzerland)2021

DDS and OPC UA Protocol Coexistence Solution in Real-Time and Industry 4.0 Context Using Non-Ideal Infrastructure.

Alexandru Ioana, Adrian Korodi

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexandru IoanaDepartment of Automation and Applied Informatics, Faculty of Automation and Computers, University Politehnica Timișoara, 300223 Timișoara, Romania.
Adrian KorodiDepartment of Automation and Applied Informatics, Faculty of Automation and Computers, University Politehnica Timișoara, 300223 Timișoara, Romania.ORCID 0000-0003-2519-7578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuing the evolution towards Industry 4.0, the industrial communication protocols represent a significant topic of interest, as real-time data exchange between multiple devices constitute the pillar of Industrial Internet of Things (IIoT) scenarios. Although the legacy protocols are still persistent in the industry, the transition was initiated by the key Industry 4.0 facilitating protocol, the Open Platform Communication Unified Architecture (OPC UA). OPC UA has to reach the envisioned applicability, and it therefore has to consider coexistence with other emerging real-time oriented protocols in the production lines. The Data Distribution Service (DDS) will certainly be present in future architectures in some areas as robots, co-bots, and compact units. The current paper proposes a solution to evaluate the real-time coexistence of OPC UA and DDS protocols, functioning in parallel and in a gateway context. The purpose is to confirm the compatibility and feasibility between the two protocols alongside a general definition of criteria and expectations from an architectural point of view, pointing out advantages and disadvantages in a neutral manner, shaping a comprehensive view of the possibilities. The researched architecture is meant to comply with both performance comparison scenarios and interaction scenarios over a gateway application. Considering the industrial tendencies, the developed solution is applied using non-ideal infrastructures to provide a more feasible and faster applicability in the production lines.

Indexed as

Internet of ThingsCommunicationIndustryRecordsDDSindustrial internet of thingsindustrial protocolsIndustry 4.0interoperabilityOPC UApublish-subscribereal-time

Identifiers

PMID34833838
PMCPMC8620391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.